论文部分内容阅读
心得安治疗高血压、冠心病及心律失常的疗效已得到了肯定,1965年Snow氏首先将其用于治疗急性心肌梗塞(AMI),并取得初步疗效,但由于无对照组,故未能得到公认。近十年来,通过大量的临床观察,再次肯定了疗效。根据wengex等统计,在过去的十年内,对无并发症的AMI患者,在一般医师,内科医师及心脏科医师中常规应用β-阻滞剂者各占32～38%,出院后常规应用者约占前一数字的1/3。
Treatment of hypertension, coronary heart disease and arrhythmia efficacy has been affirmed, in 1965, Snow’s first for the treatment of acute myocardial infarction (AMI), and achieved initial effect, but because of no control group, it is not available accepted. Over the past decade, through a large number of clinical observations, once again confirmed the efficacy. According to wengex and other statistics, in the past ten years, the uncomplicated AMI patients, general physicians, physicians and cardiologists routine use of β-blockers were 32 to 38%, after discharge of conventional users About 1/3 of the previous figure.